This symposium was developed and funded by the medical department of Bristol Myers Squibb.
At the 2023 European Society for Medical Oncology (ESMO) Annual Congress, held in Madrid, Spain, Jürgen Wolf, University Hospital Cologne, Germany; Tina Cascone, MD Anderson Cancer Center, Houston, Texas, USA; and Jose Luis Campo-Cañaveral de la Cruz, Puerta de Hierro Majadahonda University Hospital, Madrid, Spain, discussed how the latest data in non-small cell lung cancer may impact treatment selection within an increasingly complex landscape, and the role of the multidisciplinary team in optimising treatment outcomes for patients with resectable disease.
